Kanyos Bio, Inc., A Wholly-owned Subsidiary Of Anokion Sa

This study tested an experimental drug called KAN-101 in 128 adults with celiac disease who had been on a gluten-free diet for at least a year. The goal was to see if the drug could reduce the immune response triggered by gluten. The trial was stopped early, and results are being…